D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Launched by UNIVERSITY OF AARHUS · Mar 27, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis," is focused on understanding how vitamin D and certain immune cells called macrophages interact in patients with Idiopathic Pulmonary Fibrosis (IPF), a serious lung condition. The researchers want to find out if people with IPF have low levels of vitamin D and whether their macrophages are behaving in ways that could worsen lung damage. By studying these factors, they hope to learn more about the disease and potentially improve treatment options in the future.

To participate in this study, individuals must be diagnosed with IPF, a type of lung disease, or have another specific lung condition. They also need to understand and speak Danish, as this is important for communication during the trial. If eligible, participants will engage in observations and tests that help the researchers gather information without undergoing any new treatments. This study is currently recruiting participants aged between 65 and 74 years, and anyone interested in contributing to this important research can reach out for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A clinical diagnosis of IPF, non-IPF ILD or lung cancer
• • A signed informed consent
• Exclusion Criteria:
• • Do not speak Danish/Do not understand Danish